Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Bio-Techne (TECH) over the last 9 years, with Q4 2021 value amounting to $39.3 million.

  • Bio-Techne's Shares Outstanding (Weighted Average) rose 159.99% to $39.3 million in Q4 2021 from the same period last year, while for Dec 2021 it was $39.3 million, marking a year-over-year increase of 159.99%. This contributed to the annual value of $38.7 million for FY2021, which is 142.93% up from last year.
  • As of Q4 2021, Bio-Techne's Shares Outstanding (Weighted Average) stood at $39.3 million, which was up 159.99% from $39.1 million recorded in Q3 2021.
  • In the past 5 years, Bio-Techne's Shares Outstanding (Weighted Average) ranged from a high of $39.3 million in Q4 2021 and a low of $37.3 million during Q2 2017
  • In the last 5 years, Bio-Techne's Shares Outstanding (Weighted Average) had a median value of $38.0 million in 2019 and averaged $38.1 million.
  • In the last 5 years, Bio-Techne's Shares Outstanding (Weighted Average) increased by 25.48% in 2017 and then soared by 159.99% in 2021.
  • Bio-Techne's Shares Outstanding (Weighted Average) (Quarter) stood at $37.4 million in 2017, then rose by 0.85% to $37.8 million in 2018, then grew by 1.06% to $38.2 million in 2019, then grew by 1.37% to $38.7 million in 2020, then increased by 1.6% to $39.3 million in 2021.
  • Its Shares Outstanding (Weighted Average) stands at $39.3 million for Q4 2021, versus $39.1 million for Q3 2021 and $38.7 million for Q2 2021.